Glofitamab in combination with immunochemotherapy in patients with relapsed/refractory B‐cell non‐Hodgkin lymphoma: Phase 1b dose‐escalation study
- DOI
- 10.1111/bjh.70741
- Published
- 2026-08-17
- Container
- British Journal of Haematology
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/bjh.70741,
title = {Glofitamab in combination with immunochemotherapy in patients with relapsed/refractory B‐cell non‐Hodgkin lymphoma: Phase 1b dose‐escalation study},
author = {William Townsend and Nilanjan Ghosh and Martin Hutchings and Michael Dickinson and Monica Tani and Armando Santoro and Michael Crump and Amitkumar Mehta and Reinhard Marks and Martin Weisser and Martin Barrett and Chun Wu and Derrick Kaufman and Katharina Lechner and Pauline Baumlin and Pontus Lundberg and Max S. Topp},
year = {2026},
journal = {British Journal of Haematology},
doi = {10.1111/bjh.70741},
url = {https://doi.org/10.1111/bjh.70741}
}RIS
TY - JOUR TI - Glofitamab in combination with immunochemotherapy in patients with relapsed/refractory B‐cell non‐Hodgkin lymphoma: Phase 1b dose‐escalation study AU - William Townsend AU - Nilanjan Ghosh AU - Martin Hutchings AU - Michael Dickinson AU - Monica Tani AU - Armando Santoro AU - Michael Crump AU - Amitkumar Mehta AU - Reinhard Marks AU - Martin Weisser AU - Martin Barrett AU - Chun Wu AU - Derrick Kaufman AU - Katharina Lechner AU - Pauline Baumlin AU - Pontus Lundberg AU - Max S. Topp PY - 2026 JO - British Journal of Haematology DO - 10.1111/bjh.70741 UR - https://doi.org/10.1111/bjh.70741 ER -
APA
Townsend, W., Ghosh, N., Hutchings, M., Dickinson, M., Tani, M., Santoro, A., Crump, M., Mehta, A., Marks, R., Weisser, M., Barrett, M., Wu, C., Kaufman, D., Lechner, K., Baumlin, P., Lundberg, P., & Topp, M. S. (2026). Glofitamab in combination with immunochemotherapy in patients with relapsed/refractory B‐cell non‐Hodgkin lymphoma: Phase 1b dose‐escalation study. British Journal of Haematology. https://doi.org/10.1111/bjh.70741
Source records
- crossref · retrieved 2026-09-25T22:38:06.362Z